2025 Europe PMC Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
[Sponsored supplement] Striking the right CHORD: A primary care perspective on tackling obesity in the UK Diabetes Distilled: Nutritional, functional and psychological considerations for incretin-based therapies International Congress on Obesity 2026: Incretin therapies, cardiovascular risk and excessive gestational weight gain Case report: Diabetic ketoacidosis a rare but serious side-effect of SGLT2 inhibitors Are you a healthcare professional
Cagrilintides most advanced data actually come from combining it with an incretin (semaglutide), while retatrutides come from packing three receptor activities into one molecule
Which vitamins are effective for fatigue and drowsiness
I just wanted the prescription and the plan
Gould Rothberg BE, Berger AJ, Molinaro AM, Subtil A, Krauthammer MO, Camp RL et al